Back
NovaBay Pharmaceuticals Stock Price Chart

7 Stocks to Consider Immediately (must-see chart)
See the green days for 7 major stocks right here, free of charge
Sell
39
NBY
NovaBay Pharmaceuticals
Last Price:
$0.60
Seasonality Move:
-19.9%
7 Day Trial
ALL ACCESS PASS
$
7

ALERT: Q3 Could Be a Pivotal Quarter for Nasdaq Stocks
Click Here to Download Your FREE Stock Report Now-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NBY is experiencing slight buying pressure.
NovaBay Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.62 | Buy |
20-day SMA: | 0.61 | Buy |
50-day SMA: | 0.59 | Buy |
200-day SMA: | 0.62 | Buy |
8-day EMA: | 0.15 | Buy |
20-day EMA: | 0.06 | Buy |
50-day EMA: | 0.03 | Buy |
200-day EMA: | 0.01 | Buy |
NovaBay Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.05 | Buy |
Relative Strength Index (14 RSI): | 65.38 | Buy |
Chaikin Money Flow: | 2978 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.57 - 0.63) | Buy |
Bollinger Bands (100): | (0.55 - 0.63) | Buy |
NovaBay Pharmaceuticals Technical Analysis
Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for NovaBay Pharmaceuticals Stock
Is NovaBay Pharmaceuticals Stock a Buy?
-
NovaBay Pharmaceuticals share price is 0.66 while NBY 8-day simple moving average is 0.62, which is a Buy signal.
-
The stock price of NBY is 0.66 while NovaBay Pharmaceuticals 20-day SMA is 0.61, which makes it a Buy.
-
NovaBay Pharmaceuticals 50-day simple moving average is 0.59 while NBY share price is 0.66, making it a Buy technically.
-
NBY stock price is 0.66 and NovaBay Pharmaceuticals 200-day simple moving average is 0.62, creating a Buy signal.
NBY Technical Analysis vs Fundamental Analysis
Sell
39
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy or a Sell?
-
NovaBay Pharmaceuticals stock is rated a SellThe current NovaBay Pharmaceuticals [NBY] share price is $0.66. The Score for NBY is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
NovaBay Pharmaceuticals Stock Info
Market Cap:
3.9M
Price in USD:
0.66
Share Volume:
37.2K
NovaBay Pharmaceuticals 52-Week Range
52-Week High:
2.45
52-Week Low:
0.36
Sell
39
NovaBay Pharmaceuticals (NBY)
is a Sell
NovaBay Pharmaceuticals Share Price Forecast
-
What is the NovaBay Pharmaceuticals stock price today?The NovaBay Pharmaceuticals stock price is 0.66 USD today.
-
Will NBY stock go up or go down?NovaBay Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is NovaBay Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, NovaBay Pharmaceuticals is overvalued.
Is NovaBay Pharmaceuticals Stock a Buy?
-
NovaBay Pharmaceuticals share price is 0.66 while NBY 8-day exponential moving average is 0.15, which is a Buy signal.
-
The stock price of NBY is 0.66 while NovaBay Pharmaceuticals 20-day EMA is 0.06, which makes it a Buy.
-
NovaBay Pharmaceuticals 50-day exponential moving average is 0.03 while NBY share price is 0.66, making it a Buy technically.
-
NBY stock price is 0.66 and NovaBay Pharmaceuticals 200-day simple moving average is 0.01, creating a Buy signal.
Fundamental Analysis of NovaBay Pharmaceuticals
Is NovaBay Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.57 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.40 per share, and an increase next year of $0.48 per share.
Technical Analysis of NovaBay Pharmaceuticals
Should I short NovaBay Pharmaceuticals stock?
-
NBY Moving Average Covergence Divergence (MACD) indicator is 0.05, suggesting NovaBay Pharmaceuticals is a Buy
-
NovaBay Pharmaceuticals Relative Strength Index (RSI) is 65.38, which suggest NovaBay Pharmaceuticals is overbought
-
The Bollinger Bands (25) for NovaBay Pharmaceuticals is (0.57 - 0.63), which suggest NovaBay Pharmaceuticals is a Buy
-
The Bollinger Bands (100) for NovaBay Pharmaceuticals is (0.55 - 0.63), which suggest NovaBay Pharmaceuticals is a Buy
* NovaBay Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.